Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Mirtazapine Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Mirtazapine Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 15mg Tablet
      • 1.3.3 30mg Tablet
      • 1.3.4 45mg Tablet
    • 1.4 Market Segment by Application
      • 1.4.1 Global Mirtazapine Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drug store
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Mirtazapine Drug Production Value 2014-2025
      • 2.1.2 Global Mirtazapine Drug Production 2014-2025
      • 2.1.3 Global Mirtazapine Drug Capacity 2014-2025
      • 2.1.4 Global Mirtazapine Drug Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Mirtazapine Drug Market Size CAGR of Key Regions
      • 2.2.2 Global Mirtazapine Drug Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Mirtazapine Drug Capacity by Manufacturers
      • 3.1.2 Global Mirtazapine Drug Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Mirtazapine Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Mirtazapine Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Mirtazapine Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Mirtazapine Drug Price by Manufacturers
    • 3.4 Key Manufacturers Mirtazapine Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Mirtazapine Drug Market
    • 3.6 Key Manufacturers Mirtazapine Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 15mg Tablet Production and Production Value (2014-2019)
      • 4.1.2 30mg Tablet Production and Production Value (2014-2019)
      • 4.1.3 45mg Tablet Production and Production Value (2014-2019)
    • 4.2 Global Mirtazapine Drug Production Market Share by Type
    • 4.3 Global Mirtazapine Drug Production Value Market Share by Type
    • 4.4 Mirtazapine Drug Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Mirtazapine Drug Consumption by Application

    6 Production by Regions

    • 6.1 Global Mirtazapine Drug Production (History Data) by Regions 2014-2019
    • 6.2 Global Mirtazapine Drug Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Mirtazapine Drug Production Growth Rate 2014-2019
      • 6.3.2 United States Mirtazapine Drug Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Mirtazapine Drug Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Mirtazapine Drug Production Growth Rate 2014-2019
      • 6.4.2 European Union Mirtazapine Drug Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Mirtazapine Drug Import & Export
    • 6.5 China
      • 6.5.1 China Mirtazapine Drug Production Growth Rate 2014-2019
      • 6.5.2 China Mirtazapine Drug Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Mirtazapine Drug Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Mirtazapine Drug Consumption by Regions

    • 7.1 Global Mirtazapine Drug Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Mirtazapine Drug Consumption by Type
      • 7.2.2 United States Mirtazapine Drug Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Mirtazapine Drug Consumption by Type
      • 7.3.2 European Union Mirtazapine Drug Consumption by Application
    • 7.4 China
      • 7.4.1 China Mirtazapine Drug Consumption by Type
      • 7.4.2 China Mirtazapine Drug Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Mirtazapine Drug Consumption by Type
      • 7.5.2 Rest of World Mirtazapine Drug Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Merck & Co
      • 8.1.1 Merck & Co Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Mirtazapine Drug
      • 8.1.4 Mirtazapine Drug Product Introduction
      • 8.1.5 Merck & Co Recent Development
    • 8.2 Sandoz
      • 8.2.1 Sandoz Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Mirtazapine Drug
      • 8.2.4 Mirtazapine Drug Product Introduction
      • 8.2.5 Sandoz Recent Development
    • 8.3 Teva
      • 8.3.1 Teva Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Mirtazapine Drug
      • 8.3.4 Mirtazapine Drug Product Introduction
      • 8.3.5 Teva Recent Development
    • 8.4 Mylan
      • 8.4.1 Mylan Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Mirtazapine Drug
      • 8.4.4 Mirtazapine Drug Product Introduction
      • 8.4.5 Mylan Recent Development
    • 8.5 Sun Pharmaceutical
      • 8.5.1 Sun Pharmaceutical Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Mirtazapine Drug
      • 8.5.4 Mirtazapine Drug Product Introduction
      • 8.5.5 Sun Pharmaceutical Recent Development
    • 8.6 IMPAX
      • 8.6.1 IMPAX Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Mirtazapine Drug
      • 8.6.4 Mirtazapine Drug Product Introduction
      • 8.6.5 IMPAX Recent Development
    • 8.7 Aurobindo Pharma
      • 8.7.1 Aurobindo Pharma Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Mirtazapine Drug
      • 8.7.4 Mirtazapine Drug Product Introduction
      • 8.7.5 Aurobindo Pharma Recent Development
    • 8.8 Zydus Pharmaceuticals
      • 8.8.1 Zydus Pharmaceuticals Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Mirtazapine Drug
      • 8.8.4 Mirtazapine Drug Product Introduction
      • 8.8.5 Zydus Pharmaceuticals Recent Development
    • 8.9 APOTEX
      • 8.9.1 APOTEX Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Mirtazapine Drug
      • 8.9.4 Mirtazapine Drug Product Introduction
      • 8.9.5 APOTEX Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Mirtazapine Drug Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Mirtazapine Drug Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Mirtazapine Drug Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Mirtazapine Drug Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Mirtazapine Drug Production Forecast by Type
      • 9.7.2 Global Mirtazapine Drug Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Mirtazapine Drug Sales Channels
      • 10.2.2 Mirtazapine Drug Distributors
    • 10.3 Mirtazapine Drug Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Mirtazapine, sold under the brand name Remeron among others, is an antidepressant primarily used to treat depression.
      In 2019, the market size of Mirtazapine Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Mirtazapine Drug.

      This report studies the global market size of Mirtazapine Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Mirtazapine Drug production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck & Co
      Sandoz
      Teva
      Mylan
      Sun Pharmaceutical
      IMPAX
      Aurobindo Pharma
      Zydus Pharmaceuticals
      APOTEX

      Market Segment by Product Type
      15mg Tablet
      30mg Tablet
      45mg Tablet

      Market Segment by Application
      Hospital
      Drug store

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Mirtazapine Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Mirtazapine Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Mirtazapine Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now